These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10746975)
1. Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: its applicability for antileukemia immunotherapy. Osman Y; Takahashi M; Zheng Z; Toba K; Liu A; Furukawa T; Narita M; Aizawa Y; Koike T; Shibata A J Exp Clin Cancer Res; 1999 Dec; 18(4):485-92. PubMed ID: 10746975 [TBL] [Abstract][Full Text] [Related]
2. Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients. Osman Y; Takahashi M; Zheng Z; Koike T; Toba K; Liu A; Furukawa T; Aoki S; Aizawa Y Leukemia; 1999 Feb; 13(2):166-74. PubMed ID: 10025889 [TBL] [Abstract][Full Text] [Related]
3. Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapy. Gallagher RC; Waterfall M; Samuel K; Turner ML Vox Sang; 2007 May; 92(4):351-60. PubMed ID: 17456159 [TBL] [Abstract][Full Text] [Related]
4. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
5. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2. Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494 [TBL] [Abstract][Full Text] [Related]
6. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells]. Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108 [TBL] [Abstract][Full Text] [Related]
7. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen]. He B; Qiu G; Xie X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345 [TBL] [Abstract][Full Text] [Related]
8. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy. Onaitis MW; Kalady MF; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333 [TBL] [Abstract][Full Text] [Related]
9. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620 [TBL] [Abstract][Full Text] [Related]
10. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA]. Ge W; You SG; Wang YF; Li CH; Liu XF; He XP; Ma S; Qiu L Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235 [TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of dendritic cell-derived exosomes. Quah BJ; O'Neill HC Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838 [TBL] [Abstract][Full Text] [Related]
12. [Specific induction of anti-leukemia effects by umbilical cord cell-derived CD8+ T cytotoxic lymphocytes]. Liu X; Tan H; Wang CY; Huang ZQ; Zhang HZ Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):452-5. PubMed ID: 17147247 [TBL] [Abstract][Full Text] [Related]
13. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes. Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
16. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells. May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141 [TBL] [Abstract][Full Text] [Related]
17. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response]. Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332 [TBL] [Abstract][Full Text] [Related]
18. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide. Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491 [TBL] [Abstract][Full Text] [Related]